Drugs / carvedilol MR
carvedilol MR
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00123903 | Jul 2005 → May 2006 | congestive heart failure | GlaxoSmithKline | Terminated | No outcome recorded |
| Phase 3 | NCT00108082 | Jan 2005 → Aug 2008 | heart disorder | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | carvedilol MR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00108082 ↗ |
| Known as | Carvedilol Phosphate Modified Release Formulation | “Carvedilol Phosphate Modified Release Formulation (COREG MR)” NCT00123903 ↗ |
| Known as | COREG MR | “Carvedilol Phosphate Modified Release Formulation (COREG MR)” NCT00123903 ↗ |